Liza Laws speaks with Nikesh Shah, VP, global head of drug safety and pharmacovigilance, and Dr Siva Kumar Buddha, director of pharmacovigilance and head of signal and risk management at Indegene, on how evolving technologies and methodologies are enhancing the detection, evaluation and management of drug safety signals, ensuring patient safety and regulatory compliance.
We have placed cookies on your device to help make this website better. You can adjust your cookie settings, otherwise we'll assume you're okay to continue.